388 related articles for article (PubMed ID: 22084594)
1. Tryptophan, Neurodegeneration and HIV-Associated Neurocognitive Disorder.
Davies NW; Guillemin G; Brew BJ
Int J Tryptophan Res; 2010; 3():121-40. PubMed ID: 22084594
[TBL] [Abstract][Full Text] [Related]
2. The kynurenine pathway and neurodegenerative disease.
Maddison DC; Giorgini F
Semin Cell Dev Biol; 2015 Apr; 40():134-41. PubMed ID: 25773161
[TBL] [Abstract][Full Text] [Related]
3. Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases.
Lovelace MD; Varney B; Sundaram G; Lennon MJ; Lim CK; Jacobs K; Guillemin GJ; Brew BJ
Neuropharmacology; 2017 Jan; 112(Pt B):373-388. PubMed ID: 26995730
[TBL] [Abstract][Full Text] [Related]
4. Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple Sclerosis.
Lovelace MD; Varney B; Sundaram G; Franco NF; Ng ML; Pai S; Lim CK; Guillemin GJ; Brew BJ
Front Immunol; 2016; 7():246. PubMed ID: 27540379
[TBL] [Abstract][Full Text] [Related]
5. The kynurenine pathway activities in a sub-Saharan HIV/AIDS population.
Bipath P; Levay PF; Viljoen M
BMC Infect Dis; 2015 Aug; 15():346. PubMed ID: 26285873
[TBL] [Abstract][Full Text] [Related]
6. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A
Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788
[TBL] [Abstract][Full Text] [Related]
7. Indoleamine 2,3-dioxygenase as a novel therapeutic target for Huntington's disease.
Boros FA; Klivényi P; Toldi J; Vécsei L
Expert Opin Ther Targets; 2019 Jan; 23(1):39-51. PubMed ID: 30449219
[TBL] [Abstract][Full Text] [Related]
8. Kynurenine pathway metabolites in humans: disease and healthy States.
Chen Y; Guillemin GJ
Int J Tryptophan Res; 2009; 2():1-19. PubMed ID: 22084578
[TBL] [Abstract][Full Text] [Related]
9. Searching for Peripheral Biomarkers in Neurodegenerative Diseases: The Tryptophan-Kynurenine Metabolic Pathway.
Török N; Tanaka M; Vécsei L
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33302404
[TBL] [Abstract][Full Text] [Related]
10. Overview of the role of vitamins and minerals on the kynurenine pathway in health and disease.
Majewski M; Kozlowska A; Thoene M; Lepiarczyk E; Grzegorzewski WJ
J Physiol Pharmacol; 2016 Feb; 67(1):3-19. PubMed ID: 27010891
[TBL] [Abstract][Full Text] [Related]
11. Genetic alterations affecting the genes encoding the enzymes of the kynurenine pathway and their association with human diseases.
Boros FA; Bohár Z; Vécsei L
Mutat Res Rev Mutat Res; 2018; 776():32-45. PubMed ID: 29807576
[TBL] [Abstract][Full Text] [Related]
12. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K; Robotka H; Toldi J; Vécsei L
J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
[TBL] [Abstract][Full Text] [Related]
13. The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations.
Tan L; Yu JT; Tan L
J Neurol Sci; 2012 Dec; 323(1-2):1-8. PubMed ID: 22939820
[TBL] [Abstract][Full Text] [Related]
14. Degradation of tryptophan in neurodegenerative disorders.
Widner B; Leblhuber F; Walli J; Tilz GP; Demel U; Fuchs D
Adv Exp Med Biol; 1999; 467():133-8. PubMed ID: 10721050
[TBL] [Abstract][Full Text] [Related]
15. Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease.
Bonda DJ; Mailankot M; Stone JG; Garrett MR; Staniszewska M; Castellani RJ; Siedlak SL; Zhu X; Lee HG; Perry G; Nagaraj RH; Smith MA
Redox Rep; 2010; 15(4):161-8. PubMed ID: 20663292
[TBL] [Abstract][Full Text] [Related]
16. Kynurenine pathway in Parkinson's disease-An update.
Venkatesan D; Iyer M; Narayanasamy A; Siva K; Vellingiri B
eNeurologicalSci; 2020 Dec; 21():100270. PubMed ID: 33134567
[TBL] [Abstract][Full Text] [Related]
17. IDO and Kynurenine Metabolites in Peripheral and CNS Disorders.
Huang YS; Ogbechi J; Clanchy FI; Williams RO; Stone TW
Front Immunol; 2020; 11():388. PubMed ID: 32194572
[TBL] [Abstract][Full Text] [Related]
18. Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines.
Tanaka M; Toldi J; Vécsei L
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244523
[TBL] [Abstract][Full Text] [Related]
19. Tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase 1 make separate, tissue-specific contributions to basal and inflammation-induced kynurenine pathway metabolism in mice.
Larkin PB; Sathyasaikumar KV; Notarangelo FM; Funakoshi H; Nakamura T; Schwarcz R; Muchowski PJ
Biochim Biophys Acta; 2016 Nov; 1860(11 Pt A):2345-2354. PubMed ID: 27392942
[TBL] [Abstract][Full Text] [Related]
20. The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease.
Campesan S; Green EW; Breda C; Sathyasaikumar KV; Muchowski PJ; Schwarcz R; Kyriacou CP; Giorgini F
Curr Biol; 2011 Jun; 21(11):961-6. PubMed ID: 21636279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]